CGM traces added to DCCT data can predict microvascular diabetes complications similarly to glycated hemoglobin.

UVA researchers found that continuous glucose monitor data can predict nerve, eye, and kidney damage from type 1 diabetes.

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

(Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system.

The CGM study aims to find out what normally glucose levels are ... research in Bristol hears the voices of all women living in the Bristol area. MAP A Co-design Study MAP A Co-design project is being ...

United States Continuous Glucose Monitoring (CGM) Market Synopsis This market report is based on an inclusive study of the entire United States Continuous Glucose Monitoring (CGM) market.

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by Type 1 diabetes, researchers at the University of Virginia Center for Diabetes Technology have found.

Synthetic CGM data was generated using an FDA-approved ... Glucose Management Indicators (GMIs) ranged from 6.0% to 9.0%. Study design. The setup above shows the evaluation procedure for a single ...

Time-in-range computed from virtual CGM data predicts retinopathy ... similarly to glycated hemoglobin, according to a study published online in Diabetes Technology & Therapeutics.